Cargando…
Monoclonal Antibodies for Protozoan Infections: A Future Reality or a Utopic Idea?
Following the SARS-CoV-2 pandemic, several clinical trials have been approved for the investigation of the possible use of mAbs, supporting the potential of this technology as a therapeutic approach for infectious diseases. The first monoclonal antibody (mAb), Muromonab CD3, was introduced for the p...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8545981/ https://www.ncbi.nlm.nih.gov/pubmed/34712683 http://dx.doi.org/10.3389/fmed.2021.745665 |